George Scangos
2019
In 2019, George Scangos earned a total compensation of $3.9M as President and Chief Executive Officer at Vir Biotechnology, a 404% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $260,044 |
|---|---|
| Option Awards | $3,158,780 |
| Salary | $514,583 |
| Other | $11,200 |
| Total | $3,944,607 |
Scangos received $3.2M in option awards, accounting for 80% of the total pay in 2019.
Scangos also received $260K in non-equity incentive plan, $514.6K in salary and $11.2K in other compensation.
Rankings
In 2019, George Scangos' compensation ranked 3,042nd out of 13,971 executives tracked by ExecPay. In other words, Scangos earned more than 78.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,042 out of 13,971 | 78th |
Division Manufacturing | 1,100 out of 5,695 | 81st |
Major group Chemicals And Allied Products | 368 out of 2,194 | 83rd |
Industry group Drugs | 302 out of 1,880 | 84th |
Industry Biological Products, Except Diagnostic Substances | 71 out of 389 | 82nd |
Source: SEC filing on April 6, 2020.
Scangos' colleagues
We found two more compensation records of executives who worked with George Scangos at Vir Biotechnology in 2019.